27
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Helicobacter pylori

, &
Pages 33-46 | Published online: 08 Jul 2009

References

  • Jones D M, Corry A. The genesis of coccal forms of H. pylori in H. pylori gastritis and peptic ulcer. H. pylori, gastritis and peptic ulcer, P Malfertheiner, H Ditschuneit. Springer-Verlag, Berlin 1990; 29–37
  • Bode G, Malfertheiner P, Ditschuneit H. Coccoid forms of H. pylori are viable. Italian J Gastroenterol 1991; 23: 35–6, Suppl 2 Abstract
  • Megraud F, Bonnet F, Garnier M, Lamouliatte H. Characterization of 'Campylobacter pyloridis' by culture, enzymatic profile, and protein content. J Clin Microbiol 1985; 22: 1007–10
  • Hazell S L, Evans D J, Jr, Graham DY. Helicobacter pylori catalase. J Gen Microbiol 1991; 137: 57–61
  • Geis G, Leying H, Sauerbaum S, Opferkuch W. Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori. J Clin Microbiol 1990; 28: 930–2
  • Goodwin C S, Collins M D, Blincow E. The absence of thermoplasmaquinones in Campylobacter pyloridis and its temperature and pH growth range. Microbios Lett 1986; 32: 137–40
  • Steer HW. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut 1984; 25: 1203–10
  • Wyatt J I, Rathbone B J, Dixon M F, Heatley RV. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987; 40: 841–8
  • Caselli M, Bovolenta M R, Aleotti E. Epithelial morphology of duodenal bulb and campylobacter-like organisms. J Submicrosc Cytol Pathol 1988; 20: 237–42
  • Talley N J, Cameron A J, Shorter R G, Zinsmeister A R, Phillips SF. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc 1988; 63: 1176–80
  • Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus. Gastroenterology 1988; 95: 216–8
  • Graham DY. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc 1988; 63: 1258–60
  • DeCothi G A, Newbold K M, O'Connor HJ. Campylobacter-like organism and heterotopic gastric mucosa in Meckel's diverticula. J Clin Pathol 1989; 42: 132–4
  • Pambianco D J, Dye K R, Marshall B J, Frierson H F, McMillan R H, Franquemont D, et al. Gastritis in the rectum: Campylobacter-like organisms in heterotopic inflamed gastric mucosa. Gastroenterology 1988; 94: A340
  • Wyatt J I, Rathbone B J, Heatley RV. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol 1986; 38: 863–70
  • Rathbone B J, Wyatt J I, Worsley B W, Shires S E, Trejdosiewicz L K, Heatley R V, et al. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 1986; 27: 642–7
  • Hazell S L, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986; 153: 658–63
  • Bode G, Malfertheiner P, Ditschuneit H. Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease. Scand J Gastroenterol 1988; 25–39, Suppl 142
  • Langenberg M L, Tytgat G NJ, Schipper M E, Rietra P JG, Zanen C. Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet 1984; i: 1348–9
  • Hazell S L, Lee A. Campylbacter pyloridis, urease, hydrogenion back diffusion, and gastric ulcers. Lancet 1986; 2: 15–7
  • Eaton K A, Brooks C L, Mogran D R, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59: 2470–5
  • Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; 1: 1167–8
  • Chittajallu R S, Neithercut W D, Macdonald A MI, McColl K EL. Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentration. Gut 1991; 32: 21–4
  • Nujumi A ME, Dorrian C A, Chittajallu R S, Neithercut W D, McColl K EL. Effect of inhibition of H. pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut 1991; 32: 866–71
  • Thomson L, Tasman-Yones L, Morris A, Wiggins P, Lee S, Forlong C. Ammonia produced by Campylobacter pylori neutralizes H+ moving through gastric mucus. Scand J Gastroenterol 1989; 24: 761–8
  • Thomson L, Tasman-Jones C, Morris A. Na+/H+ Ion-exchange property of postmortem human gastric mucus. The effects of Campylobacter pylori infection and sucralfate. Scand J Gastroenterol 1989; 24: 781–6
  • Murakami M, Yoo J K, Inada M, Miyake T. Effect of ammonia on the gastric mucosa in rats: pathophysiological importance of urease in gastric ulcer disease. Jpn J Pharmacol 1988; 47: 330–2
  • Hazell S L, Borody T J, Gal A, Lee A. Campylobacter pyloridis gastritis I: Detection of urease as a marker of bacterial colonization and gastritis. Am J Gastroenterol 1987; 82: 292–6
  • Parsons C L, Stauffer C, Mulholland S G, Griffith DP. Effect of ammonium on bacteria adherence to bladder transitional epithelium. J Urol 1984; 132: 365–6
  • Mai U E, Perez-Perez G I, Allen J B, Wahl S M, Blaser M J, Smith PD. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992; 175: 517–25
  • Leunk R D, Johnson P T, David B C, Kraft W G, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93–9
  • Tee W, Lambert J R, Pegorer M, Dwyer B. Cytotoxin production by H. pylori more common in peptic ulcer disease. Gastroenterology 1993; 104: A789
  • Eaton K A, Morgan D R, Krakowka S. Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun 1989; 57: 1119–25
  • Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno R A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27: 225–6
  • Cover T L, Dooley C P, Blaser MJ. Characterization of human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603–10
  • Figura N, Crabtree JE. Helicobacter pylori vacuolating toxin. Helicobacter pylori: Basic mechanisms to clinical cure. 1994; 222–31
  • Vargas M, Lee A, Fox J G, Cave DR. Inhibition of acid secretion from parietal cells by non-human-infecting Helicobacter species: a factor in colonization of gastric mucosa?. Infect Immun 1991; 59: 3694–9
  • Cave D R, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989; 2: 187–9
  • Slomiany B L, Nishikawa H, Piotrowski J, Okazaki K, Slomiany A. Lipolytic activity of Campylobacter pylori, effect of sofalcone. Digestion 1989; 43: 33–40
  • Kawano S, Tsujii M, Nagano K, Ogihara T, Tanimura H, Hayashi N, et al. Different effect of Helicobacter pylori on the human gastric antral and body mucosal intracellular mucin. Scand J Gastroenterol 1990; 25: 997–1003
  • Evans D G, Evans D J, Jr, Graham DY. Adherence and internalization of Helicobacter pylori by HEP-2 cells. Gastroenterology 1992; 102: 1557–67
  • Wyle F A, Tarnawski A, Schulman D, Dabros W. Evidence for gastric mucosal cell invasion by C. pylori: an ultrastructural study. J Clin Gastroenterol 1990; 92–8, Suppl 1
  • Fauchere J L, Blaser BJ. Adherence of Helicobacter pylori cells and their surface components to HeLa cell membranes. Microb Pathogen 1990; 9: 427–39
  • Evans D J, Jr, Evans D G, Kirkpatrick S S, Graham DY. Characterization of the Helicobacter pylori urease and purification of its subunits. Microb Pathogen 1991; 10: 15–26
  • Doig P, Austin J W, Kostrzynsk A M, Trust TJ. Production of a conserved adhesin by the human gastroduodenal pathogen Helicobacter pylori. J Bacteriol, 192(174)2539–47
  • Evans D G, Evans D J, Moulds J J, Graham DY. N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun 1988; 56: 2898–906
  • Steer H W, Hawtin P R, Newell DG. An ELISA technique for the serodiagnosis of Campylobacter pyloridis infection in patients with gastritis and benign duodenal ulceration. Serodiagn Immunother 1987; 1: 253–9
  • Mitchell H M, Bohane T D, Berkowicz J, Hazell S L, Lee A. Antibody to Campylobacter pylori in families of index children with gastrointestinal illness due to C. pylori [letter]. Lancet 1987; 2: 681–2
  • Perez-Perez G I, Dworkin B M, Chodos J E, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11–7
  • Newell D G, Stacey A R, Hawlin PR. The B-cell immune response to Helicobacter pylori. Basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publisher, Dordrecht 1994; 309–20
  • Ernst P B, Reyes V, Jin Y, Navarro J, Crowe SE. Overview of the immune response to Helicobacter pylori. Basic mechanisms to clinical cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publisher, Dordrecht 1994; 295–305
  • Deusch K. T-Cell subsets: responses to Helicobacter pylori. Proceedings of the Helicobacter pylori. Basic mechanisms to clinical cure., R H Hunt, G NJ Tytgat. Kluwer Academic Publisher, Dordrecht 1994
  • Crabtree J E, Taylor J D, Wyatt J I, Heatley R U, Shallcross TM. Mucosal IgA recognition of H. pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 1991; 338: 332–5
  • Slomiany B L, Piotrowski J, Sengupta S, Slomiany A. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun 1991; 175: 963–70
  • Tee W, Lambert J R, Smallwood R, Schembri M, Ross B C, Dwyer B. Ribotyping of Helicobacter pylori from clinical specimens. J Clin Microbiol 1992; 30: 1562–7
  • Graham D Y, Malaty H M, Evans D G, Evans DJ, Jr, Klein P D, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race and socioeconomic status. Gastroenterology 1991; 100: 1495–501
  • Morris A, Nicholson G, Lloyd G, Haines D, Rogers A, Taylor D. Seroepidemiology of Campylobacter pyloridis. N Z Med J 1986; 99: 657–9
  • Megraud F, Brassens-Rabbe M P, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989; 27: 1870–3
  • Gnarpe H, Unge P, Blomqvist C, Makitalo S. Campylobacter pylori in Swedish patients referred for gastroscopy. Acta Pathol Microbiol Scand 1988; 96: 128–32
  • Weir R D, Backet EM. Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer. Gut 1968; 9: 75–83
  • Lin S K, Lambert J R, Chow T, Schembri M, Nicholson L, Wahlqvist M, et al. Comparison of Helicobacter pylori in three ethnic groups—evidence for oral-oral transmission. Gastroenterology 1991; 100: A111
  • Lambert J R, Lin S K, Nicholson L, Sievert W, Sharma V, Kaldor J, et al. High prevalence of Helicobacter pylori antibodies in institutionalized adults. Gastroenterology 1990; 98: A74
  • Banatvala N, Mayo K, Megraud F, Jennings R, Deeks J J, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219–21
  • Mitchell H M, Li Y Y, Hu P J, Liu O, Chen M, Du G, et al. Epidemiology of Helicobacter pylori in Southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 1992; 166: 149–53
  • Parsonnet J, Blaser M J, Perez-Perez G I, Hangnett-Bean N, Tauxe R. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102: 41–6
  • Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760–6
  • Lin S K, Lambert J R, Wahlqvist M, Schembri M, Lukito W, Nicholson L. Prevalence of Helicobacter pylori in a representative Anglo-Celtic population of urban Melbourne. Gastroenterology 1993; 104: A135
  • Dooley C P, Cohen H, Fitzgibbons P L, Bauer M, Appleman M D, Perez-Perez G I, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562–6
  • Kosunen T U, Hook J, Rautelin H I, Myllyla G. Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol 1989; 24: 110–4
  • Dwyer B, Sun N X, Kaldor J, Tee W, Lambert J R, Luppino M, et al. Antibody response to Campylobacter pylori in an ethnic group lacking peptic ulceration. Scand J Infect Dis 1988; 20: 63–8
  • Perez-Perez G I, Taylor D N, Bodhidatta L, Wongsrichanalai J, Baze W B, Dunn B E, et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990; 161: 1237–41
  • Russell R G, Wasserman S S, O'Donnoghue J M, Taylor D N, Boslego J, Moreno J G, et al. Serologic response to Helicobacter pylori among children and teenagers in northern Chile. Am J Trop Med Hyg 1993; 49: 189–91
  • Fiedorek S C, Malaty H M, Evans D L, Pumphrey C L, Casteel H B, Evans DJ, Jr, et al. Factors influencing the epidemiology of Helicobacter pylori in children. Pediatrics 1991; 88: 578–82
  • El-Moagel M A, Evans D G, Abdulghani M E, Adam W, Evans DJ, Jr, Malaty H M, et al. Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol 1990; 85: 944–8
  • Mendall M A, Goggin P M, Molineaux N, Levy J, Toosey T, Strachan D, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896–7
  • Andersen L P, Elsborg L, Justesen T. Campylobacter pylori in peptic ulcer disease. III: Symptoms and paraclinical and epidemiologic findings. Scand J Gastroenterol 1988; 23: 347–50
  • Diet, life-style and mortality in China, J Chen, T C Camplell, J Li, et al. Oxford University Press, Oxford 1990; 382
  • Bateson MC. Cigarette smoking and Helicobacter pylori infection. Postgrad Med J 1993; 69: 41–4
  • Hook-Nikanne J. Effect of alcohol consumption on the risk of Helicobacter pylori infection. Digestion 1991; 50: 92–8
  • Loeb D S, Talley N J, Ahlquist D A, Carpenter H A, Zinsmeister AR. Long-term non-steroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992; 102: 1899–905
  • Whitaker C J, Dubiel A J, Galpin OP. Social and geographical risk factors in Helicobacter pylori infection. Epidemiol Infect 1993; 111: 63–70
  • Webberly M J, Webberley J M, Newell D G, Lowe P, Melikian V. Seroepidemiology of Helicobacter pylori infection in vegans and meateaters. Epidemiol Infect 1992; 108: 457–62
  • Hopkins R J, Vial P A, Ferreccio C, Ovalle J, Prado P, Sotomayor V, et al. Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis 1993; 168: 222–6
  • Hook-Nikanne J, Sistonen P, Kosunen TU. Effect of ABO blood group and secretor status on the frequency of Helicobacter pylori antibodies. Scand J Gastroenterol 1990; 25: 815–8
  • Newell D G, Hudson M J, Baskerville A. Isolation of a gastric Campylobacter-like organism from the stomach of four rhesus monkeys, and identification as Campylobacter pylori. J Med Microbiol 1988b; 27: 41–4
  • Reed K D, Berridge BR. Campylobacter-like organisms in the gastric mucosa of rhesus monkeys. Lab Anim Sci 1988; 38: 329–31
  • Bronsdon M A, Schoenknecht FD. Campylobacter pylori isolated from the stomach of the monkey, Macaca nemestrina. J Clin Microbiol 1988; 26: 1725–8
  • Itoh T, Hirata I, Terayama T, Shingaki M, Takahashi S, Nakano M, . Isolation of Campylobacter pylori from the stomach of Cynomolgus monkeys and experimental infection of the cynomolgus monkeys with the organisms. Campylobacter pylori and gastroduodenal diseases, T Takemoto, K Kawai, T Shimoyama, et al. Taisho, Tokyo 1990; 2: 41–7
  • Curry A, Jones D M, Eldridge J. Spiral organisms in the baboon stomach. Lancet 1987; 2: 634–5
  • Handt L K, Fox J G, Dewhirst F E, Fraser G J, Paster B J, Yan L L, et al. Helicobacter pylori isolated from the domestic cat; public health implication. Infect Immun 1994; 62: 2367–74
  • Vaira D, D'Anastasio C, Holton J, Dowsett J F, Londei M, Bertoni F, et al. Campylobacter pylori in abattoir workers: is it a zoonosis?. Lancet 1988; 2: 725–6
  • Lambert J R, Lin S K, Nicholson L, Schembri M, Korman M, Coulepis A, et al. Prevalence of Helicobacter pylori in abattoir workers. Revisita Espanola de Enfermedades Digestivas, 78: 18, Suppl 1
  • Hopkins R J, Russel R G, O'Donnoghue J M, Wasserman S S, Lefkowitz A, Morris JG. Seroprevalence of Helicobacter pylori in seventh-day adventists and other groups in Maryland. Lack of association with diet. Arch Intern Med 1990; 150: 2347–8
  • Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192–9
  • Marshall B J, Armstrong J A, McGeichie D B, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436–9
  • Klein P D, Graham D Y, Gaillour A, Opekun A R, Smith EO. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Lancet 1991; 337: 1503–6
  • Nowottny U, Heilmann KL. Epidemiology of Helicobacter pylori infection. Leber Magen Darm 1990; 20: 183–6; 180
  • Berkowicz J, Lee A. Person-to-person transmission of Campylobacter pylori [letter]. Lancet 1987; 2: 680–1
  • Hammermeister I, Janus G, Schamarowski F, Rudolf M, Jacobs E, Kist M. Elevated risk of Helicobacter pylori infection in submarine crews. Eur J Clin Microbiol Infect Dis 1992; 11: 9–14
  • Mitchell H M, Lee A, Carrick J. Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence of support person-to-person transmission of C. pylori. Scand J Gastroenterol 1989; 24: 396–400
  • Lin S K, Lambert J R, Schembri M, Nicholson L, Korman MG. Helicobacter pylori prevalence in endoscopy and medical staff. J Gastroenterol Hepatol 1994; 9: 6
  • Malaty H M, Graham D Y, Klein P D, Evans D G, Adam E, Evans DJ. Transmission of Helicobacter pylori infection. Studies in families of healthy individuals. Scand J Gastroenterol 1991; 26: 927–32
  • Drumm B, Perez-Perez G I, Blaser M J, Sherman PM. Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med 1990; 322: 359–63
  • Lin S K, Lambert J R, Hardikar W, Nicholson L, Schembri M. Helicobacter pylori infection in families—evidence for person-to-person transmission. Italian J Gastroenterol 1991; 23: 12, Suppl 2
  • Majewski S I, Goodwin CS. Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation. J Infect Dis 1988; 157: 465–71
  • Rauws E A, Langenberg W, Oudbier J H, Mulder C JJ, Tytgat G NJ. Familial clustering of peptic ulcer disease colonized with C. pylori of the same DNA composition. Gastroenterology 1989; 96: A409
  • Simor A E, Shames B, Drumm B, Sherman P, Low D E, Penner JL. Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol 1990; 28: 83–6
  • Valentine J L, Arthur R R, Mobley H L, Dick JD. Detection of Helicobacter pylori by using the polymerase chain reaction. J Clin Microbiol 1991; 29: 689–95
  • Mapstone N P, Lynch D A, Lewis F A, Axon A T, Tompkins D S, Dixon M F, et al. Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol 1993; 46: 540–3
  • Nguyen A M, Engstrand L, Genta R M, Graham D Y, El-Zaatari FA. Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol 1993; 31: 783–7
  • Majmudar P, Shah S M, Dhunjibhoy K R, Desai HG. Isolation of Helicobacter pylori from dental plaques in healthy volunteers. Indian J Gastroenterol 1990; 9: 271–2
  • Krajden S, Fuksa M, Anderson J, Kempston J, Boccia A, Petrea C, et al. Examination of human stomach biopsies, saliva, and dental plaque for Campylobacter pylori. J Clin Microbiol 1989; 27: 1397–8
  • Lambert I, Clyne M, Drumm B. H. pylori in dental plaques. Lancet 1993; 341: 957
  • Olsson K, Wadström T, Tyszkiewicz T. H. pylori in dental plaques. Lancet 1993; 341: 956–7
  • Banatvala N, Lopez C R, Owen R, Abdi Y, Davies G, Hardie J, et al. Helicobacter pylori in dental plaque. Lancet 1993; 341: 380
  • Thomas J E, Gibson G R, Darboe M K, Dale A, Weaver LT. Isolation of Helicobacter pylori from human feces. Lancet 1992; 340: 1194
  • Mapstone N P, Lynch D A, Lewis F A, Axon A T, Tompkins D S, Dixon M F, et al. PCR identification of Helicobacter pylori in feces from gastritis patients. Lancet 1993; 341: 447
  • Luzzi I, Pezzella C, Caprioli A, Covacci A, Bugnoli M, Censini S. Detection of vacuolating toxin of Helicobacter pylori in human feces. Lancet 1993; 341: 1348
  • Lin S K, Lambert J R, Schembri M, Nicholson L, Korman MG. Comparison of Helicobacter pylori prevalence in practising dental staff and gastroenterologists. Presented at Annual Scientific Meeting of the Gastroenterological Society of Australia, Brisbane 1992
  • Malaty H M, Evans D J, Jr, Abramovitch K, Evans D G, Graham DY. Helicobacter pylori infection in dental workers: a seroepidemiology study. Am J Gastroenterol 1992; 87: 1728–31
  • Polish L B, Douglas JM, Jr, Davidson A J, Perez-Perez G I, Blaser MJ. Characterization of risk factors for Helicobacter pylori infection among men attending a sexually transmitted disease clinic: lack of evidence for sexual transmission. J Clin Microbiol 1991; 29: 2139–43
  • Graham D Y, Alpert L C, Smith J L, Yoshimura HH. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988; 83: 974–80
  • Langenberg W, Rauws E A, Oudbier J H, Tytgat G NJ. Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis 1990; 161: 507–11
  • Katoh M, Saito O, Noda T, Yoshida S, Oguro Y, Yazaki Y, et al. Helicobacter pylori may be transmitted through gastrofiberscope even after manual Hyamine washing. Jpn J Cancer Res 1993; 84: 117–9
  • Marshall B J, McGechie D B, Rogers P A, Glancy RJ. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142: 439–44
  • Lambert J R, Dunn K, Borromeo M, Korman M G, Harisky J. Campylobacter pylori—a role in non-ulcer dyspepsia?. Scand J Gastroenterol 1989; 7–13, Suppl 160
  • Feng Y Y, Wang Y. Campylobacter pylori in patients with gastritis, peptic ulcer, and carcinoma of the stomach in Lanzhou, China [Letter]. Lancet 1988; 1: 1055
  • Pettross C W, Appleman M D, Cohen H, Valenzvela J E, Chandrasona P, Laine LA. Prevalence of Campylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms. Dig Dis Sci 1988; 33: 649–53
  • Inouye H, Yamamoto I, Tanida N, Mikami J, Tamura K, Ohno T, et al. Campylobacter pylori in Japan: bacteriological feature and prevalence in healthy subjects and patients with gastroduodenal disorders. Gastroenterol Jpn 1989; 24: 494–504
  • Niemala S, Karttunen T, Lehtola J. Campylobacter-like organisms in patients with gastric ulcer. Scand J Gastroenterol 1987; 22: 487–90
  • Jiang S J, Liu W Z, Zhang D Z, Shi Y, Xiao S D, Zhang Z H, et al. Campylobacter-like organisms in chronic gastritis, peptic ulcer, and gastric carcinoma. Scand J Gastroenterol 1987; 22: 553–8
  • Lofeld R J, Potters H V, Arends J W, Stobberingh E, Flendrig J A, van Spreeuwel JP. Campylobacter-associated gastritis in patients with non-ulcer dyspepsia. J Clin Pathol 1988; 41: 85–8
  • Rauws E A, Langenberg W, Houthoff H J, Zanen H C, Tytgat G NJ. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33–40
  • Blomberg B, Järnerot G, Kjellander J, Danielssson D, Kraaz W. Prevalence of Campylobacter pylori in an unselected Swedish population of patients referred for gastroscopy. Scand J Gastroenterol 1988; 23: 358–62
  • Cheng E H, Bermanski P, Silversmith M, Valenstein P, Kawanishi H. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease. Arch Intern Med, 189: 1373–5; 149
  • Cohen H, Gramisu M, Fitzgibbons P, Appleman M, Skoglund M, Valenzuela JE. Campylobacter pylori: associations with antral and fundic mucosal histology and diagnosis by serology in patients with upper gastrointestinal symptoms. Am J Gastroenterol 1989; 84: 367–71
  • Lambert JR. The role of Helicobacter pylori in non-ulcer dyspepsia: a debate for Gastroenterol. Clin N Am 1993; 22: 141–51
  • Bayerdörffer E, Kasper G, Pirlet R, Sommer A, Ottenjann R. Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer-a prospective controlled randomized study. Dtsch Med Wochenschr 1987; 112: 1407–11
  • Marshall B J, Goodwin C S, Warren J R, Murray R, Blincow E D, Blackbourn S J, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1439–42
  • Graham D Y, Opekun A, Lew G M, Evans DJ, Jr, Klein P D, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990; 85: 394–8
  • Lambert J R, Borromeo M, Korman MG. Effect of colloidal bismuth (DeNol) on healing and relapse of duodenal ulcer-role of C. pyloridis. Gastroenterology 1987; 92: 1489
  • Graham D Y, Lew G M, Klein P D, et al. Results of treatment of Helicobacter pylori infection in the recurrence of gastritis or duodenal ulcers: a randomized single-blind, single center study. Gastroenterology 1991; 100: A74
  • Grigorjev P Y, Aruin L I, Isakow VA. DeNol plus oxacillin vs ranitidine and oxacillin in H.p.-positive duodenal ulcers: effects on relapse. Rev Esp Enferm Dig 1990; 78: 129, Suppl 1
  • Murakami A, Tadam T, Yanai H, et al. Effect of Helicobacter pylori on gastric mucosal blood flow. Proceedings of World Congresses of Gastroenterology. Sydney 1990
  • McColl K E, Fullarton G M, Nujumi A M, et al. Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer [Letter]. Lancet 1989; 2: 499
  • Mooney C, Keenan J, Munster D, Wilson I, Allardyce R, Bagshaw P, et al. Neutrophilactivation by Helicobacter pylori. Gut 1991; 32: 853–7
  • Fukuda T, Kimura S, Arakawa T, Kobayashi K. Possible role of leukotrienes in gastritis associated with Campylobacter pylori. J Clin Gastroenterol 1990; 131–4, Suppl 12
  • Le A, Lambert J R, Davenport P, Finlay M, Soveny C, Tipping P, et al. Antral mucosal gastrin and tumour necrosis factor-alpha release in patients with non-ulcer dyspepsia and H. pylori infection. Gastroenterology 1993; 104: A1047
  • Denizot Y, Sobhani I, Rambaud J C, Lewin M, Thomas Y, Benveniste J. Paf-acether synthesis by Helicobacter pylori. Gut 1990; 31: 1242–5
  • Le A, Finlay M, Lambert J R, Savino R, Soveny C, Midolo P. Antral gastrin and somatostatin cells in Helicobacter pylori subjects: restitution of D-cell number with eradication. Gastroenterology 1993; 104: A1046
  • Haruma K, Sumii K, Okamoto S, Yoshihara M, Tari A, Teixeira C R, et al. Helicobacter pylori infection causes low antral somatostatin content: pathogenesis of inappropriate hypergastrinemia. Gastroenterology 1992; 102: A80
  • Moss S F, Legon S, Bishop A E, Polak J M, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930–2
  • Golodner E H, Territo M C, Walsh J H, Soil AH. Stimulation of gastrin release from cultured canine G-cells by Helicobacter pylori and mononuclear cells. Gastroenterology 1992; 102: A630
  • Le A, Shulkes A, Lambert J R, Lin S K, Tipping P. Effect of tumour necrosis factor-alpha and bombesin on antral mucosal gastrin and somatostatin: influence of H. pylori infection. Gastroenterology 1993; 104(4)
  • Omar E, Penman I, Dorrian C A, Ardill J ES, McColl K EL. Eradicating H. pylori lowers gastrin-mediated acid secretion by 70% in DU patients and by 50% in healthy volunteers. Gastroenterology 1993; 104: A75
  • Sievert W, Allwell L, Lambert J R, Hansky J, Soveny C, Korman MG. Gastrin release and acid secretion are a critical function of H. pylori infection. Proceedings of the American Gastroenterological Association Annual meeting. New OrleansUSA 1994
  • Martin D F, Montgomery E, Bobek A S, Patrissi G A, Peura DA. Campylobacter pylori NSAIDs and smoking risk factors for peptic ulcer disease. Am J Gastroenterol 1989; 84: 1268–72
  • Heresbach D, Raoul J L, Donnio P Y, Siproudhis L, Minet J, et al. Helicobacter pylori: a risk and severity factor in NSAIDs induced gastropathy. Gastroenterology 1991; 100: A82
  • Katz B, Lambert J R, Nicholson L, Lin S K, Schembri M, Morand E, et al. Helicobacter pylori infection, upper gastrointestinal (UGI) symptoms and blood loss in patients with rheumatoid arthritis on NSAID. Gastroenterology 1991; 100: A96
  • Graham D Y, Lew G M, Klein P D, Evans D G, Evans DJ, Jr, Saedd Z A, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer—a randomized controlled study. Ann Intern Med 1992; 116: 705–8
  • Seppala K. H. pylori a.d. gastric ulcers in H. pylori-basic. mechanism to clinical cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publisher, Dordrecht
  • Fox J G, Correa P, Taylor N S, Zavala D, Fontham E, Janney F, et al. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol 1989; 84: 775–81
  • Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin N Am 1993; 22: 89–104
  • Fox JG. Animal models for Helicobacter pylori induced gastric and hepatic cancer: Basic mechanisms to clinical cure in Helicobacter, R H Hunt, G NJ Tytgat. Kluwer Academic Publisher, Dordrecht 1994; 504–22
  • Wotherspoon A C, Ortiz-Hidalgo C, Falzon M R, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–6
  • Hussell T, Isaacson P G, Crabtree J E, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571–4
  • Stolte M, Eidt S, Bayerdörffer E. Helicobacter pylori-associated gastric lymphoma. Proceedings of the Helicobacter pylori. Basic mechanisms to clinical cure in Helicobacter., R H Hunt, G NJ Tytgat. Kluwer Academic Publisher, Dordrecht 1994; 498–503
  • Wotherspoon A C, Doglioni C, Diss T C, Pan L, Moschini A, de-Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–7
  • Langenberg W, Rauws E A, Houthoff H J, Oudbier J H, van Bohemen C G, Tytgat G NJ, et al. Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of non-infected persons with non-ulcer dyspepsia. J Infect Dis 1988; 157: 1245–9
  • Cutler A F, Schubert TT. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993; 88: 1359–61
  • Forbes G M, Glaser M E, Cullen D JE, Warren J R, Christiansen K J, Marshall B J, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258–60
  • Costas M, Owen R J, Bickley J, Morgan DR. Molecular techniques for studying the epidemiology of infection by Helicobacter pylori. Scand J Gastroenterol 1991; 20–32, Suppl 181
  • Khandaker K, Palmer K R, Eastwood M A, Scott A C, Desai M, Owen RJ. DNA fingerprints of Helicobacter pylori from mouth and antrum of patients with chronic ulcer dyspepsia. Lancet 1993; 342: 751
  • Lin S K, Lambert J R, Schembri M, Nicholson L, Finlay M, Wong C, et al. A comparison of diagnostic tests to determine Helicobacter pylori infection. J Gastroenterol Hepatol 1992; 7: 203–9
  • Clancy R, Cripps A, Webster V, Taylor D, McShane L. Detection of antibody in saliva as an aid to management in Helicobacter pylori infection. Proceedings of the Helicobacter pylori: Basic mechanisms to clinical cure. FloridaUSA 1993; 31
  • Alemohammad M M, Foley T J, Cohen H. Detection of immunoglobulin G-antibodies to Helicobacter pylori in urine by an enzyme immunoassay method. J Clin Microbiol, 193: 2174–7; 31
  • Lambert J R, Lin S K, Schembri M, Nicholson L, Korman MG. Helicobacter pylori therapy randomized study of DeNol/ antibiotic combinations. In Rev Esp Enf Dig. Third Workshop of the European Helicobacter pylori Study Group. Toledo 1990; 115–6
  • Burette A, Glupczynski Y, Deprez C. Combined therapy with ofloxacin and amoxicillin in the eradication of Helicobacter pylori. Gastroenterology 1990; 98: A26
  • DeKoster E, Nyst J F, Glupczynski Y, et al. Short-term double drug Helicobacter pylori treatment: one week amoxicillin + tinidazole versus amoxicillin + nitrofurantoin. Gastroenterology 1990; 98: A35
  • Burette A, Glupczynski Y. Evaluation of four short-term amoxicillin/tinidazole regimens for eradication of Helicobacter pylori. In Rev Esp Enf Dig. Third Workshop of the European Helicobacter pylori Study Group. Toledo 1990; 78: 94–5, Suppl 1
  • Unge P, Eriksson K, Bergman B, Carling L, Ekström P, Gad A, et al. Omeprazole and amoxicillin in patients with duodenal ulcer: Helicobacter pylori eradication and remission of ulcers and symptoms during a 6 months' following. A double-blind comparative study. Gastroenterology 1993; 102: A183
  • Bayerdörffer E, Mannes G A, Sommer A, Hochter W, Weingart J, Hatz R, et al. High-dose omeprazole treatment combined with amoxicillin eradication Helicobacter pylori. Gastroenterology 1992; 102: A38
  • Raws E AJ, Tytgat G NJ. Helicobacter pylori treatment of gastritis. Helicobacter pylori and Gastroduodenal Disease, B J Rathbone, R V Heatley, 1992; 232
  • Borsch G, Mai U, Opferkuch W. Oral triple therapy may effectively eradicate Campylobacter pylori in man: a pilot study. Gastroenterology 1988; 94: A44
  • Lamouliatte H, Bernhard P H, Cayla R, et al. Controlled study of omeprazole-amoxicillin-tinidazole vs ranitidine-amoxicillin-tinidazole in Helicobacter pylori-associated duodenal ulcer (DU): final and long-term results. Gastroenterology 1992; 102: A106
  • Borody T J, Brandi S, Andrews P, Ostapowicz N, Jamkiewicz E. High efficacy low-dose triple therapy (TT) for Helicobacter pylori. Gastroenterology 1992; 102: A44
  • Marshall B J, Dye K R, Plankey M, et al. Eradication of Campylobacter pylori infection with bismuth subsalicylate and antibiotic combinations. Am J Gastroenterol 1988; 83: 1035
  • Hentschel E, Hirschl A M, Shutze K, Dufer W. Amoxicillin and metronidazole in the eradication of Campylobacter pylori. Klin Wochenschr 1989; 67: 29, Suppl XVIII
  • Arena G, Lambert J R, King R G, Onishi N, Midolo P, Nicholson L, et al. Enhanced amoxicillin uptake into the human gastric mucosa at lower gastric juice pH. Gastroenterology 1993; 104: A34
  • Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T, Kubo K, et al. Lansoprazole, a novel benizimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35: 490–6
  • Borody T J, George L L, Brandi S, Andrews P, Lenne J, Moore-Jones D, et al. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy. Scand J Gastroenterol 1992; 27: 281–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.